TG THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
TG THERAPEUTICS, INC. (TGTX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.51 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 15.62M shares, a 2.91% decline year-over-year.
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 16.09M shares, a 7.80% increase year-over-year.
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 14.93M shares, a 5.04% increase year-over-year.
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 14.21M shares, a 12.26% increase year-over-year.
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 16.40M shares, a 9.36% increase from fiscal 2024.
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 15.00M shares, a 13.91% increase from fiscal 2023.
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 13.17M shares, a 4.10% increase from fiscal 2022.
- TG THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 12.65M shares, a 4.74% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 15.51M shares 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 15.62M shares 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | 16.40M shares 10-K · filed 2026-02-27 | |||
| 2025-09-30 | 15.58M shares 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 15.82M shares 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | 16.09M shares 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | 15.00M shares 10-K · filed 2026-02-27 | |||
| 2024-09-30 | 15.61M shares 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | 14.87M shares 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 14.93M shares 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | 13.17M shares 10-K · filed 2026-02-27 | |||
| 2023-09-30 | 13.48M shares 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 13.46M shares 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | 14.21M shares 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | 12.65M shares 10-K · filed 2025-03-03 | |||
| 2022-09-30 | 16.34M shares 10-Q · filed 2023-11-06 | |||
| 2022-06-30 | 13.51M shares 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | 12.66M shares 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | 13.28M shares 10-K · filed 2024-02-29 | |||
| 2021-09-30 | 13.13M shares 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | 13.26M shares 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | 12.13M shares 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 11.98M shares 10-K · filed 2023-03-01 | |||
| 2020-09-30 | 11.10M shares 10-Q · filed 2020-11-09 | 11.10M shares 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | 10.54M shares 10-Q · filed 2020-08-10 | 10.54M shares 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | 8.58M shares 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | 8.36M shares 10-K · filed 2022-03-01 | |||
| 2019-09-30 | 8.06M shares 10-Q · filed 2020-11-09 | 8.06M shares 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | 7.84M shares 10-Q · filed 2020-08-10 | 7.84M shares 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | 6.77M shares 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | 6.53M shares 10-K · filed 2021-03-01 | |||
| 2018-09-30 | 5.23M shares 10-Q · filed 2019-11-12 | 5.23M shares 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | 5.17M shares 10-Q · filed 2018-08-09 | 5.17M shares 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | 4.66M shares 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | 4.84M shares 10-K · filed 2020-03-02 | |||
| 2017-09-30 | 4.16M shares 10-Q · filed 2018-11-09 | 4.16M shares 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | 4.29M shares 10-Q · filed 2018-08-09 | 4.29M shares 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | 3.63M shares 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | 8.03M shares 10-K · filed 2019-03-01 | |||
| 2016-09-30 | 6.66M shares 10-Q · filed 2017-11-09 | 6.66M shares 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | 6.45M shares 10-Q · filed 2017-08-09 | 6.45M shares 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | 6.87M shares 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | 7.06M shares 10-K · filed 2018-03-15 | |||
| 2015-09-30 | 5.63M shares 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | 5.67M shares 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | 8.38M shares 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | 8.89M shares 10-K · filed 2017-03-16 | |||
| 2014-09-30 | 9.10M shares 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | 9.70M shares 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | 10.10M shares 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | 10.62M shares 10-K · filed 2016-03-15 | |||
| 2013-09-30 | 9.99M shares 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | 10.11M shares 10-Q · filed 2013-08-09 | |||
| 2013-03-31 | 10.42M shares 10-Q · filed 2014-05-14 | |||
| 2012-12-31 | 10.75M shares 10-K · filed 2014-03-07 | |||
| 2012-09-30 | 7.48M shares 10-Q · filed 2013-11-14 | |||
| 2012-06-30 | 7.43M shares 10-Q · filed 2013-08-09 | |||
| 2012-03-31 | 14.15M shares 10-Q · filed 2013-05-14 | |||
| 2011-12-31 | 5.32M shares 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |